Telomir Pharmaceuticals (TELO) Non Operating Income (2023 - 2025)
Telomir Pharmaceuticals (TELO) posted Non Operating Income of $44182.0 for Q3 2025, up 455.47% sequentially from $7954.0 in Q1 2025, and up 186.06% YoY from $15445.0 in Q3 2024.
Telomir Pharmaceuticals (TELO) Non Operating Income (2023 - 2025) Analysis & Trends
Telomir Pharmaceuticals has reported Non Operating Income for 3 years, with the latest figure at $44182.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 234.30 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -53.64 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -51.63 Mn |
| 10 | Telomir Pharmaceuticals | 69.05 Mn | 69.05 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 44,182.00 |
| Mar 31, 2025 | 7,954.00 |
| Sep 30, 2024 | 15,445.00 |
| Mar 31, 2024 | -4.34 Mn |
| Sep 30, 2023 | -757,173.00 |